NO176095C - Analogifremgangsmåte av terapeutisk aktive indan- og kinolin-derivater - Google Patents

Analogifremgangsmåte av terapeutisk aktive indan- og kinolin-derivater

Info

Publication number
NO176095C
NO176095C NO914602A NO914602A NO176095C NO 176095 C NO176095 C NO 176095C NO 914602 A NO914602 A NO 914602A NO 914602 A NO914602 A NO 914602A NO 176095 C NO176095 C NO 176095C
Authority
NO
Norway
Prior art keywords
therapeutically active
quinoline derivatives
analogous method
indane
active indane
Prior art date
Application number
NO914602A
Other languages
English (en)
Norwegian (no)
Other versions
NO914602L (no
NO914602D0 (no
NO176095B (no
Inventor
Karnail Atwal
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NO914602D0 publication Critical patent/NO914602D0/no
Publication of NO914602L publication Critical patent/NO914602L/no
Publication of NO176095B publication Critical patent/NO176095B/no
Publication of NO176095C publication Critical patent/NO176095C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/28Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/26Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
NO914602A 1990-11-26 1991-11-25 Analogifremgangsmåte av terapeutisk aktive indan- og kinolin-derivater NO176095C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61835790A 1990-11-26 1990-11-26

Publications (4)

Publication Number Publication Date
NO914602D0 NO914602D0 (no) 1991-11-25
NO914602L NO914602L (no) 1992-05-27
NO176095B NO176095B (no) 1994-10-24
NO176095C true NO176095C (no) 1995-02-01

Family

ID=24477368

Family Applications (1)

Application Number Title Priority Date Filing Date
NO914602A NO176095C (no) 1990-11-26 1991-11-25 Analogifremgangsmåte av terapeutisk aktive indan- og kinolin-derivater

Country Status (17)

Country Link
US (1) US5401848A (pl)
EP (1) EP0488616A1 (pl)
JP (1) JPH04352753A (pl)
KR (1) KR920009783A (pl)
CN (1) CN1061961A (pl)
AU (1) AU637535B2 (pl)
CA (1) CA2054637A1 (pl)
FI (1) FI915530A7 (pl)
HU (1) HU209470B (pl)
IE (1) IE913867A1 (pl)
IL (1) IL99902A0 (pl)
NO (1) NO176095C (pl)
NZ (1) NZ240615A (pl)
PL (1) PL166983B1 (pl)
PT (1) PT99605A (pl)
RU (1) RU2058980C1 (pl)
ZA (1) ZA918539B (pl)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651105B2 (en) * 1990-06-18 1994-07-14 E.R. Squibb & Sons, Inc. Benzopyran derivatives and heterocyclic analogs thereof as antiischemic agents
US5453421A (en) * 1992-09-11 1995-09-26 E. R. Squibb & Sons, Inc. Aryl and heterocyclic substituted propenamide derivatives
US5374643A (en) * 1992-09-11 1994-12-20 E. R. Squibb & Sons, Inc. Aryl urea (thiourea) and cyanoguanidine derivatives
US5514690A (en) * 1992-11-17 1996-05-07 E. R. Squibb & Sons, Inc. Aminocarbonyl (thiocarbonyl) and cyanoguanidine derivatives of quinoline and indoline
GB9225860D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
GB9225859D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
US5401758A (en) * 1993-10-07 1995-03-28 Bristol-Myers Squibb Company Pyridinyl cyanoguanidine compounds
WO1995033726A1 (en) * 1994-06-09 1995-12-14 Ss Pharmaceutical Co., Ltd. 4-quinolinone derivative or salt thereof
US5612370A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phenylglycine and phenylalaninen amido benzopyran derivatives
US5612323A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phosphinic ester substituted benzopyran derivatives
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
US5629429A (en) * 1995-06-07 1997-05-13 Bristol-Myers Squibb Company Process for preparing 4-arylamino-benzopyran and related compounds
WO1997026300A1 (en) * 1996-01-22 1997-07-24 Eli Lilly And Company Combinatorial process for preparing substituted indane libraries
US6083986A (en) * 1996-07-26 2000-07-04 Icagen, Inc. Potassium channel inhibitors
US6333337B1 (en) 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
AU4997199A (en) * 1998-07-16 2000-02-07 Axys Pharmaceuticals, Inc. Process for the synthesis of benzopyran derivatives
GT199900147A (es) 1998-09-17 1999-09-06 1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas.
US6147090A (en) * 1998-09-17 2000-11-14 Pfizer Inc. 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
US6197786B1 (en) * 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
US6140342A (en) * 1998-09-17 2000-10-31 Pfizer Inc. Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
US6147089A (en) * 1998-09-17 2000-11-14 Pfizer Inc. Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
WO2001046155A1 (en) * 1999-12-21 2001-06-28 Icagen, Inc. Potassium channel inhibitors
US6566380B2 (en) * 2000-07-25 2003-05-20 Icagen, Inc. Potassium channel inhibitors
US6620849B2 (en) 2000-07-26 2003-09-16 Icafen, Inc. Potassium channel inhibitors
US6849634B2 (en) 2000-12-21 2005-02-01 Icagen Potassium channel inhibitors
BRPI0510642A (pt) 2004-05-05 2007-11-20 Hoffmann La Roche arilsulfonil benzodioxanos úteis para modulação do receptor de 5-ht6, do receptor de 5ht2a ou ambos
ES2314749T3 (es) 2004-12-21 2009-03-16 F. Hoffmann-La Roche Ag Derivados de tetralina y de indano y usos de los mismos como antagonistas de 5-ht.
JP4738418B2 (ja) 2004-12-21 2011-08-03 エフ.ホフマン−ラ ロシュ アーゲー クロマン誘導体及びcns障害の処置におけるその使用
ATE455755T1 (de) 2004-12-21 2010-02-15 Hoffmann La Roche Tetralin- und indanderivate und deren anwendungen
RU2396264C2 (ru) 2004-12-21 2010-08-10 Ф. Хоффманн-Ля Рош Аг Производные хромана и их применение в качестве лигандов 5-нт рецептора
MX2007007481A (es) 2004-12-21 2007-07-20 Hoffmann La Roche Derivados de tetralina e indano y usos de los mismos.
CN100381398C (zh) * 2005-07-29 2008-04-16 南京理工大学 AlN-Si3N4-SiC陶瓷材料的制备方法
ES2359735T3 (es) 2005-11-03 2011-05-26 F. Hoffmann-La Roche Ag Arilsulfonilcromanos como inhibidores de 5-ht6.
WO2007147763A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Arylsulfonyl naphthalene derivatives and uses thereof
EP2035370A2 (en) 2006-06-20 2009-03-18 F. Hoffmann-Roche AG Tetralin and indane derivatives and uses thereof
KR101064001B1 (ko) 2006-06-20 2011-09-08 에프. 호프만-라 로슈 아게 아릴설폰아미딜 테트랄린 유도체 및 이의 용도
CN107540566A (zh) * 2017-08-28 2018-01-05 江苏绿叶农化有限公司 一种炔苯酰草胺的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3486354T2 (de) * 1983-05-18 1995-03-30 Beecham Group Plc Chroman- und Chromenderivate.
GB8414987D0 (en) * 1984-06-12 1984-07-18 Beecham Group Plc Active compounds
DE3579390D1 (de) * 1984-06-22 1990-10-04 Beecham Group Plc Wirksame benzopyranverbindungen.
DE3583780D1 (de) * 1984-08-31 1991-09-19 Otsuka Pharma Co Ltd 2,3-dihydro-1h-inden-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
AU609232B2 (en) * 1987-12-14 1991-04-26 Beecham Group Plc Novel indane derivatives possessing smooth muscle relaxant activity
GB8730052D0 (en) * 1987-12-23 1988-02-03 Beecham Group Plc Novel compounds
US4988723A (en) * 1988-06-02 1991-01-29 Fujisawa Pharmaceutical Co., Ltd. Benzopyran derivatives and their use as anti-hypertensives
ATE139775T1 (de) * 1988-09-16 1996-07-15 Beecham Group Plc Benzopyranderivate mit einer blutdrucksenkenden wirkung
EP0386839B1 (en) * 1989-03-08 1997-01-15 Merck Sharp & Dohme Ltd. Tetrahydroquinoline derivatives useful for neurodegenerative disorders
AU632809B2 (en) * 1989-05-25 1993-01-14 Takeda Chemical Industries Ltd. Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof
US5140031A (en) * 1989-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Pyranyl cyanoguanidine derivatives

Also Published As

Publication number Publication date
HUT60467A (en) 1992-09-28
RU2058980C1 (ru) 1996-04-27
FI915530A0 (fi) 1991-11-25
PL166983B1 (pl) 1995-07-31
NZ240615A (en) 1994-05-26
EP0488616A1 (en) 1992-06-03
KR920009783A (ko) 1992-06-25
NO914602L (no) 1992-05-27
IE913867A1 (en) 1992-06-03
JPH04352753A (ja) 1992-12-07
NO914602D0 (no) 1991-11-25
HU913664D0 (en) 1992-02-28
IL99902A0 (en) 1992-08-18
FI915530A7 (fi) 1992-05-27
PT99605A (pt) 1992-10-30
PL292536A1 (en) 1992-09-21
HU209470B (en) 1994-06-28
CN1061961A (zh) 1992-06-17
NO176095B (no) 1994-10-24
ZA918539B (en) 1992-08-26
AU8804091A (en) 1992-05-28
US5401848A (en) 1995-03-28
CA2054637A1 (en) 1992-05-27
AU637535B2 (en) 1993-05-27

Similar Documents

Publication Publication Date Title
NO176095C (no) Analogifremgangsmåte av terapeutisk aktive indan- og kinolin-derivater
PH27400A (en) New therapeutically active compound and method of use thereof
NO170483C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrahydronaftalin- og indanderivater
LU90736I2 (fr) Agenerase-amprenavir et ses d-riv-s pharmaceutiquement acceptables
FI905284L (fi) Menetelmä kiinnirullauksessa
NO173545C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO850614L (no) Fremgangsmaate for fremstilling av antibakterielle kinolin- og naftyridin-derivater
HU9300034D0 (en) Derivatives of quinolone and of naphtyridone-carboxylic acid
MA23226A1 (fr) Derives optiquement actifs de 2-imidazoline-5-ones et 2-imidazoline-
FI881900A7 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten substituoitujen imidatsolyylialkyylipiperatsiini- ja -diatsepiinijohdannaisten valmistamiseksi
NO178498C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive karbapenemderivater
NO175528C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive fenylacetamid-derivater
KR890700602A (ko) 면역억제성 펩타이드 및 사용방법
NO178543C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzopyranderivater
NO852729L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme benzimidazol- og benzotiazolderivater
NO179449C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzazepin- og benzotiazepin-derivater
NO172849C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazol- og oksazol-derivater
NO850615L (no) Fremgangsmaate for fremstilling av antibakterielle kinolin- og naftyridin-derivater
FI894604L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyridyyli- ja pyrimidyylipiperatsiinijohdannaisten valmistamiseksi
FI904838A7 (fi) Menetelmä farmaseuttisesti aktiivisten karboksitetrahydroisokinoliinien ja niiden johdannaisten valmistamiseksi
NO176100C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive oksodihydropyridyl- og oksodihydropyridazinylkromanderivater
NO178698C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive glycerolderivater
NO173606C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno- triazolo-diazepin-derivater
BR9205939A (pt) Derivados de 4-aril-3-(heteroalilureído)quinolina
NO177263C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridinderivater